当前位置： SCI文献检索 > Journal of Ginseng Research期刊下所有文献 > Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers.

Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers.

Abstract：

BACKGROUND:We evaluated the drug interaction profile of Red Ginseng (RG) with respect to the activities of major cytochrome P450 (CYP) enzymes and the drug transporter P-glycoprotein (P-gp) in healthy Korean volunteers. METHODS:This article describes an open-label, crossover study. CYP probe cocktail drugs, caffeine, losartan, dextromethorphan, omeprazole, midazolam, and fexofenadine were administered before and after RG supplementation for 2 wk. Plasma samples were collected, and tolerability was assessed. Pharmacokinetic parameters were calculated, and 90% confidence intervals (CIs) of the geometric mean ratios of the parameters were determined from logarithmically transformed data using analysis of variance after RG administration versus before RG administration. RESULTS:Fourteen healthy male participants were evaluated, none of whom were genetically defined as poor CYP2C9, 2C19, and CYP2D6 metabolizers based on genotyping. Before and after RG administration, the geometric least-square mean metabolic ratio (90% CI) was 0.870 (0.805-0.940) for caffeine to paraxanthine (CYP1A2), 0.871 (0.800-0.947) for losartan (CYP2C9) to EXP3174, 1.027 (0.938-1.123) for omeprazole (CYP2C19) to 5-hydroxyomeprazole, 1.373 (0.864-2.180) for dextromethorphan to dextrorphan (CYP2D6), and 0.824 (0.658-1.032) for midazolam (CYP3A4) to 1-hydroxymidazolam. The geometric mean ratio of the area under the curve of the last sampling time (AUClast) for fexofenadine (P-gp) was 0.963 (0.845-1.098). Administration of concentrated RG for 2 wk weakly inhibited CYP2C9 and CYP3A4 and weakly induced CYP2D6. However, no clinically significant drug interactions were observed between RG and CYP and P-gp probe substrates. CONCLUSION:RG has no relevant potential to cause CYP enzyme- or P-gp-related interactions. Clinical trial registration number (ClinicalTrials.gov): NCT02056743.

journal_name

J Ginseng Res

journal_title

Journal of ginseng research

authors

Kim DS,Kim Y,Jeon JY,Kim MG

doi

10.1016/j.jgr.2015.11.005

subject

Has Abstract

pub_date

2016-10-01 00:00:00

pages

375-381

issue

eissn

1226-8453

issn

2093-4947

pii

S1226-8453(15)00124-4

journal_volume

pub_type

杂志文章

在线工具

Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers.